BackSummary
Sana Biotechnology raised $69.0 million in net proceeds from a common stock sale, strengthening its balance sheet for ongoing operations.
Key takeaways
- Sold 21,607,878 shares of common stock via TD Securities.
- Net proceeds of approximately $69.0 million.
- Offering conducted under an amended sales agreement.
- Proceeds likely to fund research and development activities.